Company New Horizon Health Limited

Equities

6606

KYG6485S1021

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for New Horizon Health Limited

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Diagnostic & Testing Substances

Market Closed - Hong Kong S.E. Other stock markets 04:08:30 2024-03-27 am EDT			5-day change	1st Jan Change
14.14 ^HKD	-19.75%		-.--%	-38.92%

Apr. 08	New Horizon Health Limited Announces Board Appointments	CI
Mar. 28	New Horizon Health Limited Announces Delay in Publication Annual Results for the Year Ended December 31, 2023	CI

New Horizon Health Ltd is a China-based investment holding company principally engaged in the research, development, clinical development, test operation and commercialization of screening products for colorectal cancer, gastric cancer and cervical cancer. The Company distributes its ColoClear, Pupu tube and other products to customers through its own network, contracted sales organisations (CSOs) and Internet sales or e-platform operated by healthcare clinics. The Companyâs Youyou Tube (a stool-based self-checking gastric cancer screening test) and CerviClear (a non-invasive urine cervical cancer home screening test) are under development.

Number of employees: 1,041

HKD in Million	2021	Weight	2022	Weight	Delta
ColoClear 46.6 %	117	45.7 %	415	46.6 %	+253.90%
UU Tube 27.2 %	-	-	242	27.2 %	-
Pupu Tube 26.2 %	139	54.3 %	233	26.2 %	+67.63%
Others 0.0 %	0	0.0 %	0	0.0 %	-81.68%

HKD in Million	2021	Weight	2022	Weight	Delta
China 99.9 %	256	100.0 %	889	99.9 %	+246.66%
International 0.1 %	-	-	1	0.1 %	-

Managers	Title	Age	Since
Ye Qing Zhu CEO	Chief Executive Officer	52	18-06-06
Yi You Chen FOU	Founder	-	18-06-06
Yu Gao DFI	Director of Finance/CFO	41	20-05-31
Ning Lu CTO	Chief Tech/Sci/R&D Officer	53	18-06-06
Ming Wai Mok SEC	Corporate Secretary	52	21-06-10

Members of the board	Title	Age	Since
Yi You Chen FOU	Founder	-	18-06-06
Danke Yu BRD	Director/Board Member	54	21-02-16
Na Xin Yao BRD	Director/Board Member	54	20-10-08
Kwok Tung Li BRD	Director/Board Member	69	-
Ye Qing Zhu CEO	Chief Executive Officer	52	18-06-06
Hong Wu BRD	Director/Board Member	66	21-02-16

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	457,813,108	348,418,877 ( 76.11 %)	0	76.11 %

Name	Equities	%	Valuation
Qiming Venture Partners Ltd. 7.840 %	35,891,538	7.840 %	65 M $
Yi You Chen 7.798 %	35,701,053	7.798 %	65 M $
Ye Qing Zhu 6.148 %	28,146,010	6.148 %	51 M $
Na Xin Yao 5.034 %	23,044,618	5.034 %	42 M $
Legend Capital Co. Ltd. 4.967 %	22,739,746	4.967 %	41 M $
SB China Capital 4.603 %	21,074,512	4.603 %	38 M $
NHXC Holdings Ltd. 3.234 %	14,806,275	3.234 %	27 M $
Zhi Sheng Chen 2.188 %	10,017,926	2.188 %	18 M $
China Southern Asset Management Co., Ltd. 1.993 %	9,124,500	1.993 %	16 M $
OrbiMed Advisors Private Equity 1.840 %	8,422,070	1.840 %	15 M $

New Horizon Health Ltd.

13/F, T1 Building 400 Jiang'er Road

310051, Hangzhou

+86 57 1811 07210

http://www.newhorizonbio.com

address New Horizon Health Limited(6606)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

13.06 CNY

Average target price

32.48 CNY

Spread / Average Target

+148.69%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
NEW HORIZON HEALTH LIMITED	-38.92%	811M
BIOMÉRIEUX	-0.30%	12.59B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-12.53%	7.42B
DIASORIN S.P.A.	+1.72%	5.35B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.37%	4.51B
LANTHEUS HOLDINGS, INC.	+5.16%	4.47B
10X GENOMICS, INC.	-51.93%	3.21B
ANDON HEALTH CO., LTD.	+11.34%	2.71B
VITROLIFE AB	-18.44%	1.96B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.07%	1.73B

Diagnostic & Testing Substances